Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Riethmüller

Showing results (81-90 of 253) with videos related to

Pageof 26
Sort By:
Immunology|February 1, 1989
Complement activation in human lymphoid germinal centresJ Zwirner, E Felber, P Schmidt, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|March 4, 1998
[Disseminated tumor cells: diagnosis, prognostic relevance, phenotyping and therapeutic strategies]K Pantel, M von Knebel Doeberitz, J R Izbicki, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a novel surrogate test to monitor adjuvant therapies of solid tumoursG Schlimok, K Pantel, H Loibner, et al.
The Journal of Experimental Medicine|April 1, 1987
The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brainI Funke, A Hahn, E P Rieber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Micrometastases of bone marrow in localized prostate cancer: correlation with established risk factorsD Weckermann, P Müller, F Wawroschek, et al.
The Journal of Urology|July 18, 2001
Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: detection and prognostic valueD Weckermann, P Müller, F Wawroschek, et al.
Cancer Immunity|May 16, 2003
Minimal costimulatory requirements for T cell priming and TH1 differentiation: activation of naive human T lymphocytes by tumor cells armed with bifunctional antibody constructsP Kufer, F Zettl, K Borschert, et al.
Molecular Immunology|January 1, 1989
The use of fusion proteins to study HLA-B27-specific allorecognitionG Wildner, E H Weiss, H Szöts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significanceG Schlimok, I Funke, B Bock, et al.
Journal of Immunological Methods|March 13, 1995
A novel non-radioactive cellular cytotoxicity test based on the differential assessment of living and killed target and effector cellsD Flieger, R Gruber, G Schlimok, et al.
Pageof 26

Showing results (81-90 of 253) with videos related to

Sort By:
Pageof 26
Immunology|February 1, 1989
Complement activation in human lymphoid germinal centresJ Zwirner, E Felber, P Schmidt, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|March 4, 1998
[Disseminated tumor cells: diagnosis, prognostic relevance, phenotyping and therapeutic strategies]K Pantel, M von Knebel Doeberitz, J R Izbicki, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a novel surrogate test to monitor adjuvant therapies of solid tumoursG Schlimok, K Pantel, H Loibner, et al.
The Journal of Experimental Medicine|April 1, 1987
The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brainI Funke, A Hahn, E P Rieber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Micrometastases of bone marrow in localized prostate cancer: correlation with established risk factorsD Weckermann, P Müller, F Wawroschek, et al.
The Journal of Urology|July 18, 2001
Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: detection and prognostic valueD Weckermann, P Müller, F Wawroschek, et al.
Cancer Immunity|May 16, 2003
Minimal costimulatory requirements for T cell priming and TH1 differentiation: activation of naive human T lymphocytes by tumor cells armed with bifunctional antibody constructsP Kufer, F Zettl, K Borschert, et al.
Molecular Immunology|January 1, 1989
The use of fusion proteins to study HLA-B27-specific allorecognitionG Wildner, E H Weiss, H Szöts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significanceG Schlimok, I Funke, B Bock, et al.
Journal of Immunological Methods|March 13, 1995
A novel non-radioactive cellular cytotoxicity test based on the differential assessment of living and killed target and effector cellsD Flieger, R Gruber, G Schlimok, et al.
Pageof 26